Form 8-K - Current report:
SEC Accession No. 0001213900-23-029675
Filing Date
2023-04-14
Accepted
2023-04-14 06:28:51
Documents
12
Period of Report
2023-04-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea176902-8k_bimiinter.htm   iXBRL 8-K 34842
  Complete submission text file 0001213900-23-029675.txt   208575

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bimi-20230413.xsd EX-101.SCH 3221
3 XBRL LABEL FILE bimi-20230413_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bimi-20230413_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT ea176902-8k_bimiinter_htm.xml XML 3598
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 23819650
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries